2022-2023
2022/09 - 2023/06SUITE A LA SITUATION COVID, LES SEMINAIRES EN PRESENTIELS NE SONT OUVERTS QU'AUX COLLABORATEURS DU DEPARTEMENT PATIM (Y COMPRIS AFFILIES CLINIQUES). SI VOUS SOUHAITEZ NOUS REJOINDRE PAR ZOOM, MERCI DE SUIVRE LE LIEN INDIQUE SUR LE FACMED HEBDOMADAIRE. |
||||||||||||||
| Date | Time | Location | Speaker | Title | Host | Details | ||||||||
| SEPTEMBER | ||||||||||||||
| FRI 23 |
12h15-13h00 | Auditoire JL Reverdin B02.2526 |
Pr. Abhishek Garg KU Leuven, BE |
Reverse translational dendritic cells-based immunotherapy vs. T cell-hostile tumours: A tug of war! |
Paula Nunes-Hasler | |||||||||
| OCTOBER | ||||||||||||||
| FRI 07 |
12h15-13h00 |
Auditoire Franceschetti |
TDB |
TDB |
||||||||||
| FRI 21 |
12h15-13h00 | Auditoire Renold B01.2426 |
Pr Steffen Massberg University of Munich |
TBD |
Christoph Scheiermann | |||||||||
| NOVEMBER | ||||||||||||||
| FRI 04 |
12h15-13h00 |
Auditoire JL Reverdin |
Pr Brant Isakson |
An unexpected role for Pannexin 3 in cardiovascular disease |
Brenda Kwak |
|||||||||
| FRI 18 |
12h15-13h00 | Auditoire Renold B01.2426 |
TBD |
TBD | ||||||||||
| DECEMBER | ||||||||||||||
| FRI 09 |
12h15-13h00 |
TBD |
Sophia Qiqun ZENG |
Neural signaling/molecular in cancer progression |
Brenda Kwak |
|||||||||
| JANUARY | ||||||||||||||
| FRI 27 |
12h15-13h00 |
J-L. Reverdin (CMU) |
Pr. Roberto Speck |
Unprecedented anti-HIV activity of macrophages in HIV-infected iHMD-NSG mice |
Karl-Heinz Krause |
|||||||||
| FEBRUARY | ||||||||||||||
| FRI 03 |
12h15-13h00 |
B04.2222 (CMU) |
Dr. Stefano Sammicheli |
A drug is born: preclinical development of ISB 1442, a first in class CD38 X CD47 bispecific innate cell engager |
Simone Becattini |
|||||||||
| MARCH | ||||||||||||||
| FRI 10 |
12h15-13h00 |
P. Boymond (CMU) |
Pr Jerome Tamburini |
CEBPA confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress-induced ferroptosis in FLT3-mutant leukemia. |
Julien Bertrand |
|||||||||
| FRI 24 |
12h15-13h00 |
B04.2222 (CMU) |
Pr Nikolai Klymiuk |
Exploring the immune system in pig models for biomedical research |
J. Seebach |
|||||||||
| APRIL | ||||||||||||||
| FRI 28 |
12h15-13h00 | P. Boymond (CMU) |
Pr. Tim Halim |
Immune regulatory functions of ILC2 |
Camilla Jandus | |||||||||
| MAY | ||||||||||||||
| FRI 12 |
12h15-13h00 |
A. Renold (CMU) |
Pr. Aranxta Tabernero |
A Src inhibitory peptide based on connexin43 as a therapy for glioblastoma |
Brenda Kwak |
|||||||||
| FRI 26 |
12h15-13h00 | A. Renold (CMU) |
Dr. Alexandre Boissonnas |
Spatial heterogeneity of tumor-associated macrophages | Stéphanie Hugues | |||||||||
| JUNE | ||||||||||||||
| THU 1 |
TDB | PATIM RETREAT | ||||||||||||
| FRI 2 |
TDB | PATIM RETREAT | ||||||||||||
| FRI 16 |
12h15-13h00 | A. Franceschetti (CMU) |
Pr. Fabio Zampieri |
TBD | M.-L. Piallat | |||||||||
| FRI 23 |
12h15-13h00 | J-L. Reverdin (CMU) |
Pr. Maria Casanova-Acebes |
TBD |
Christoph Scheiermann |
|||||||||